Gelesis Granted FDA Clearance to Market Plenity - a New Prescription Aid in Weight Management

BOSTON, April 14, 2019— Gelesis, a biotechnology company developing first-in-class hydrogel therapeutics to treat obesity and other chronic diseases related to the gastrointestinal (GI) tract, today announced that the United States Food and...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news